CST’s New Product Developments Enabling Basic and Translational Research
Friday, March 1 2013
12:30 pm – 2:00 pm
Location: 300 Trade Center, Woburn, at Route 128. McLane Law – 6th Floor, Suite 7000
NSTC First Friday Bioscience Seminar
Anjli Venkateswaran, Ph.D, Marketing Product Manager for Cell Signalling Technology (CST) will discuss diversification beyond legacy antibodies and reagents to cutting edge products for applied systems in biological research. CST is a leader in the innovative development of new antibodies and reagents to analyze signaling pathways and biomarkers in basic research and drug discovery. The company has pioneered the development of premier rabbit monoclonal antibodies (XP®) using the proprietary XMT® technology that was developed in-house. XP antibodies show exceptional sensitivity, reproducibility and performance.
Refreshments: Complimentary pizza, salads, and soft-drinks
Cost for members and non-members:
- Members – Free (thanks to our host, PCI Synthesis, there is no charge for NSTC Members and Affiliates)
- Non-members - $10.00
Pre-register at: http://www.nstc.org
For more information send email to: FirstFridayBiosci@nstc.org
Host: PCI Synthesis is a 14-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products. A contract manufacturing organization (CMO), PCI provides emerging and mid-sized pharmaceutical companies access to the expertise needed to develop and manufacture complex small molecules and APIs used in generic pharmaceuticals. Visit www.pcisynthesis.com for more information.